Indeed, in various cancer types (e.g., bladder, non-small cell lung, ovarian, prostate cancer, and clear cell renal cell carcinoma) [62,63], RAB25 overexpression has been associated with shorter overall survival. This evidence concerns the gene RAB25 and prostate cancer.